Introduction

Fluorine is a gaseous element, which reacts with almost all kinds of metal elements to generate different fluorides widely found in nature. Fluoride (F) is most well-known for its prophylactic use over several decades to prevent dental caries via topical application or supplementation of drinking water (Yeung 2008). However, pathological effects of F intake have been reported for various organs including the brain (Wang et al. 2004a, b; Ge et al. 2005a, b; Wu et al. 2006), reproductive tissues (Zhang et al. 2006a, b, c; Wan et al. 2006a, b), thyroid gland (Ge et al. 2005c; Susheela et al. 2005), liver (Shashi 2003; Zhan et al. 2006b), kidney (Usuda et al. 1998; Guan et al. 2000; Zhan et al. 2006a), and pancreas (Matsuo et al. 2000). Furthermore, long-term excessive F intake disrupts the balance of bone deposition and remodeling activities and is linked to skeletal disease, the most prominent of which is fluorosis (Krishnamachari 1986). Fluorosis is a chronic disease caused by ingesting excessive amounts of F, mostly from water, and less often from food (Wang et al. 2002, 2003) and air (Liang et al. 1994; Wang et al. 1992, 1994). Affected organs in affected individuals include the teeth, which is referred to as dental fluorosis (Aoba and Fejerskov 2002) and bone, referred to as skeletal fluorosis (Krishnamachari 1986).

Skeletal fluorosis is characterized by extreme bone deformity with accompanying osteosclerosis, osteoporosis, osteomalacia and immobilization of joints of the axial skeleton (Krishnamachari 1986). The balance between bone deposition and resorption is tightly controlled by osteoblastic and osteoclastic activities of resident bone cells, the osteoblasts and osteoclasts, respectively (Goltzman 2002). Osteoblasts (OB) are the primary cells contributing to bone formation. Osteoblasts actively secrete type I collagen and other bone matrix components and release growth factors, enzymes and minerals into the bone matrix (Goltzman 2002). Hence, effects of excessive F intake on skeletal health could be manifest by effects on OB survival.

In the present studies, cultures of OB were established from neonatal rat calvarias. The objective of described experiments was to investigate the effects of treatment with varying concentrations of F on OB proliferation and apoptosis in vitro. To further elucidate potential mechanisms contributing to F-induced OB apoptosis, effects on treatments on caspase-3 and caspase-9 mRNA expression were also determined.

Materials and methods

Animals

Ten 24-h-old female neonatal Wistar rats were provided by the Experimental Animal Center of Shanxi Medical University (Taiyuan, China). Animals were handled in accordance with the principles of laboratory animal care and all experimental procedures were approved by the Research Commission for the Care and Use of Experimental Animal Center of Shanxi Medical University of China.

Materials and chemicals

Dulbecco’s Modified Eagle Medium (DMEM) and trypsin were obtained from Gibco (Grand Island, NY, USA). Fetal bovine serum (FBS) was purchased from Hangzhou Sijiqing Biological Engineering Material Company (Hangzhou, China). HEPES buffer was obtained from Hyclone (Logan, UT USA). NaF and MTT were purchased from Sigma (St. Louis, MO USA). The apoptosis detection kit containing Annexin-V-FITC and propidium iodide (PI) was from Becton Dickinson (San Jose, CA USA). Trizol Reagent was purchased from Invitrogen (Carlsbad, CA USA). The One-Step SYBR® RT-PCR Kit and real time PCR primers were obtained from the Takara Biotechnology Company (Dalian, China).

OB cell isolation and culture

Osteoblasts were obtained from calvarias of neonatal rats according to previously published procedures (Torricelli et al. 2003; Xue 2001) with some modifications. Approximately 1 × 10cells/ml were seeded in 25-ml tissue culture flasks containing DMEM medium supplemented with 10% fetal calf serum (FCS), 100 IU/ml penicillin, and 100 μg/ml streptomycin and cultured at 37°C in air with 5% CO2. For subculture, cells at 80–90% confluence were passaged at a ratio of 1:3 after detachment in 0.125% trypsin and 1 mM EDTA. OB were identified by morphology after Giemsa and hemotoxylin and eosin (H&E) staining, alkaline phosphatase (ALP) staining and mineralized nodule (alizarin red) staining. Treatments were applied when cells were semi confluent and were added to 5% FCS-containing medium. For experiments described below, cells were seeded in 96-well plates for cell proliferation studies or in T25 flasks for studies of F-induced apoptosis and caspase-3 and caspase-9 mRNA expression.

Cell proliferation assays

To determine effects of F on cell proliferation, OB were cultured in the presence of increasing concentrations of sodium fluoride (NaF; 0, 0.5, 5, 10, 20 and 30 mg/l) for 24, 48, 72, 96 and 120 h. Effects of F treatment on numbers of viable OB (proliferation) were assessed using the MTT assay which quantifies the ability of viable cells to convert soluble MTT dye into an insoluble dark blue formazan reaction product. At the end of each treatment period, MTT stock solution was added (1 part to 10 parts medium) to cells in each well of a 96-well tissue culture plate and cells were incubated at 37°C for 4 h. Subsequently, the medium containing MTT was removed and 150 μl dimethylsulfoxide (DMSO) was added per well to dissolve the formazan crystals. The absorbance in each well (reflective of number of live cells) was measured at 570 nm with a Bio-Rad automated EIA Analyzer.

Apoptosis assays

For studies of effects of F treatment on OB apoptosis, cells were cultured in the presence of 0, 0.5, 5, 10 and 20 mg/l NaF for 24 and 72 h. After completion of treatment periods, cells were collected by trypsinization and centrifugation, washed three times with PBS (pH 7.4) and resuspended in binding buffer at a concentration of 1 × 10cells/ml. For each sample, a total of 5 μl of Annexin V-FITC and 10 μl of 20 mg/ml PI were added and cells were incubated for 15 min in the dark before a further addition of 400 μl PBS. Quantitative analysis of OB apoptosis was performed using a FACS caliber flow cytometer (FCM, Becton Dickinson).

Real time PCR analysis of caspase-3 and caspase-9 mRNA

For studies of effects of F treatment on OB mRNA abundance for caspase-3 and caspase-9, cells were cultured in the presence of 0, 0.5, 5, 10 and 20 mg/l NaF for 24 and 72 h. Effects of F treatment on caspase-3 and caspase-9 mRNA were determined using quantitative real time RT-PCR (qRT-PCR) procedures. Primers (Table 1) for qRT-PCR were designed based on available rat sequences in Genbank for caspase-3 (NM_012922), caspase-9 (NM_031632) and β-actin (NM_031144) using Primer premier 5.0 software. The three pairs of primers were tested for their specificity by conventional reverse transcription polymerase chain reaction (RT-PCR) before being used in qRT-PCR studies and by melting curve analysis following qRT-PCR (described below).

Table 1 Primer sequences with corresponding PCR product size and accession #

The RT-PCR assays were performed on the Mx3000P™ QRT-PCR system (Stratagene, USA) and using the One-Step SYBR® QRT-PCR kit (20 μl reaction mixture). Relative quantification of mRNA abundance for caspase-3 and caspase-9 was performed using the comparative ΔΔCT method expression,with the house-keeping gene β-actin used as a calibrator (Pfaffl 2001). Thermal cycling conditions were as follows: an initial reverse transcription step of 5 min at 42°C and 40 cycles at 95°C for 10 s, 58°C for 20 s, and 72°C for 6 s. The reaction was then subjected to a melting protocol from 55 to 95°C with a 0.2°C increment and 1 s holding at each increment to verify specificity of the amplified products.

Statistical analysis

Experimental data were expressed as mean ± SEM of three independent experiments, with three replicates of each treatment/experiment. Comparisons among treatments mean for cell proliferation and apoptosis data were performed using Kruskal–Wallis two-way ANOVA. Effects of treatments on caspase-3 and caspase-9 mRNAs were determined by analysis of variance (ANOVA) for the dose-response experiments and using 2-tailed Student’s t tests. Values of P < 0.05 were considered statistically significant.

Results

Establishment of OB cultures

After 24 h in culture, cells adhered to the flasks and showed classical morphological characteristics of OB including spindle, triangle or polyangular shape as revealed by H&E staining (Fig. 1a). Oval nuclei and obvious cytoplasm were observed following Giemsa stain (Fig. 1b). Cytochemical staining for ALP in OB revealed black deposits in cytoplasm (Fig. 1c). The OB overlapped each other after reaching confluence with a single layer, at the center of which calcification occurred, forming sporadic white spots visible with the naked eye. Round red mineralized nodules were visualized by Alizarin red staining, further confirming that deposition of calcium had occurred (Fig. 1d).

Fig. 1
figure 1

Morphological and histochemical characterization of osteoblasts (OB) cultured from neonatal rat calvaria. a Hemotoxylin and eosin staining of OB cultured in vitro. Note spindle,triangle or polyangular appearance (×200). b Giemsa staining of cultured OB. Note cells with enlarged nuclei and obvious cytoplasm and cell protrusions (×200). c Alkaline phosphatase staining of cultured OB. Note black deposits in cytoplasm (×200). d Alazarin red staining of cultured OB. Note mineralized nodule stained by alizarin red with red calcified extracellular matrix (×100)

Effects of NaF treatment on OB proliferation

MTT assays were performed to determine if F treatment influences OB proliferation during 24–120 h of culture. As depicted in Fig. 2, proliferation of cells cultured in the absence of NaF (control) was evident during the 120 h of in vitro culture. Numbers of viable OB were slightly increased (relative to control) following 72 h exposure to 0.5 and 5 mg/l concentrations of NaF, but the increase was not statistically significant (P > 0.05). However, higher concentrations of NaF (20 and 30 mg/l) suppressed OB proliferation through 72 h of culture (P < 0.01). NaF at 10.0 mg/l did not influence OB proliferation after 72 h of exposure (P > 0.05). In contrast, cell proliferation was reduced following culture of OB for 96 and 120 h in the presence of all concentrations of NaF tested (P < 0.05; Fig. 2). Results indicate that extended culture in the presence of NaF dramatically inhibits OB cell proliferation.

Fig. 2
figure 2

Effects of sodium fluoride treatment on osteoblast proliferation (as determined by the MTT assay)

Effects of NaF treatment on OB cell apoptosis:

Incidence of apoptosis was determined by Annexin V-propidium iodide staining following 24 and 72 h culture in the presence of increasing concentrations of NaF. Annexin V-FITC binding is utilized to quantify phosphatidylserine residues redistributed from the inner to the outer leaflet of the cell membrane, which is an early event in apoptosis. Cell membrane integrity is lost with progression of apoptosis. Hence, binding of the membrane impermeable PI to DNA is used as an index of cells in later stages of apoptosis/dead cells (Wang et al. 2008). NaF treatment significantly increased the numbers of OB in early stages of apoptosis (Annexin V+/PI) and late stages of apoptosis/dead cells (Annexin V+/PI+) following 24 h (Fig. 3a–e) and 72 h of treatment (Fig. 4a–e). Following 24 h of treatment, the percent of Annexin V positive cells and percent of PI positive cells were significantly increased in response to as little as 0.5 mg/l NaF. The percentage of cells in early stages of apoptosis were increased by 4.42 (P < 0.05), 7.23, 13.15 and 9.72-fold (P < 0.01) in response to culture in the presence of 0.5, 5, 10 and 20 mg/l NaF, respectively, and the percentage of late apoptotic/dead OB were increased by 12.4 (P < 0.05), 13.5, 18.2 and 15.05-fold (P < 0.01), respectively, in response to the same treatments (Fig. 3f). Moreover, following 72 h exposure of OB to 0.5, 5, 10 and 20 mg/l NaF, the percentage of cells in early stages of apoptosis were increased by 5.94, 8.28, 8.74 and 11.46-fold (P < 0.01), respectively, and the percentage of late apoptotic/dead cells were increased by 4.87, 5.02, 8.51 and 22.57-fold, respectively, for the same treatments (P < 0.01) relative to control cells cultured in the absence of NaF (Fig. 4f). Results indicate that NaF treatment can induce OB apoptosis in a dose-dependent fashion.

Fig. 3
figure 3

Effect of 24-h treatment with sodium fluoride (NaF) on apoptosis of cultured osteoblasts. ae Two-dimension scatter plots depicting distribution of cells positively stained for Annexin V, propidium iodide (PI) and their combination following 24-h treatment with a 0 mg/l NaF, b 0.5 mg/l NaF, c 5 mg/l NaF, d 10 mg/l (NaF) or e 20 mg/l NaF. Cells in lower left quadrant of each picture correspond to normal cells (Annexin V /PI ). Cells in right lower quadrant correspond to early apoptotic cells (Annexin V + /PI ). Cells in right upper quadrant correspond to late apoptotic/dead cells (Annexin V + /PI +). f Quantification of effects of treatment with various concentrations of NaF on percent apoptotic osteoblasts staining positive for Annexin V and for PI. Values depicted in (f) represent the mean ± SE (** P < 0.01 relative to untreated control; * P < 0.05 relative to untreated control)

Fig. 4
figure 4

Effect of 72-h treatment with sodium fluoride (NaF) on apoptosis of cultured osteoblasts. ae Two-dimension scatter plots depicting distribution of cells positively stained for Annexin V, propidium iodide (PI) and their combination following 24-h treatment with a 0 mg/l NaF, b 0.5 mg/l NaF, c 5 mg/l NaF, d 10 mg/l (NaF) or e 20 mg/l NaF. Cells in lower left quadrant of each picture correspond to normal cells (Annexin V/PI). Cells in right lower quadrant correspond to early apoptotic cells (Annexin V+/PI). Cells in right upper quadrant correspond to late apoptotic/dead cells (Annexin V+/PI+). f Quantification of effects of treatment with various concentrations of NaF on percent apoptotic osteoblasts staining positive for Annexin V and for PI. Values depicted in (f) represent the mean ± SE (** P < 0.01 relative to untreated control)

Effect of NaF treatment on OB cell caspase-3 and caspase-9 mRNA abundance

To further investigate the potential mechanisms involved in OB cell apoptosis induced by F, qRT-PCR analysis of caspase-3 and caspase-9 mRNA abundance following 24 and 72 h incubation in the presence of increasing concentrations of NaF (0, 0.5. 5 and 20 mg/l) was conducted. No significant effects of NaF on caspase-3 and caspase-9 mRNA were observed following 24 h of treatment (Fig. 5a, b). However, treatment with 5 mg/l NaF significantly increased caspase-3 and caspase-9 mRNA abundance (P < 0.05) by over twofold following 72 h of treatment (Fig. 5c, d).

Fig. 5
figure 5

Quantitative real time PCR analysis of the effect of 24 and 72 h sodium fluoride (NaF) treatment on osteoblast (OB) caspase-3 and caspase-9 mRNA expression in vitro. a Effect of 24-h treatment with increasing doses of NaF on OB caspase-3 mRNA abundance. b Effect of 24-h treatment with increasing doses of NaF on OB caspase-9 mRNA abundance. c Effect of 72-h treatment with increasing doses of NaF on OB caspase-3 mRNA abundance. d Effect of 72-h treatment with increasing doses of NaF on OB caspase-9 mRNA abundance. Relative mRNA abundance was calculated using ΔΔCT method. Abundance of caspase-3 and caspase-9 mRNAs was normalized relative to that of β-actin mRNA. Data are shown as mean ± SE. Doses of NaF without a common superscript for each timepoint/mRNA analyzed are different at P < 0.05

Discussion

Skeletal health is dictated by the balance between bone deposition and resorption. Chronic excessive F intake has been linked to skeletal disease, such as fluorosis (Krishnamachari 1986), but the effects of F directly on bone forming cells (osteoblasts) that promote skeletal disease are not well understood. In the present studies, the effects of NaF treatment on proliferation and apoptosis of neonatal rat OB and on caspase-3 and caspase-9 mRNA expression were investigated. Collectively, results demonstrate a pronounced negative effect of F on OB survival, and suggest that such effects could potentially contribute to the abnormal bone metabolism, characteristic of F-induced skeletal diseases such as fluorosis.

Potent inhibitory effects of F treatment on OB proliferation were observed in the present studies. Culture of OB in the presence of low concentrations of NaF (0.5 and 5 mg/l) for 72 h resulted in a subtle, but nonsignificant increase in OB proliferation. Culture in the presence of higher concentrations (20 and 30 mg/l) dramatically reduced OB proliferation. Proliferation was reduced at all other timepoints examined in response to all concentrations of NaF tested. Dose-dependent effects of NaF treatment on proliferation of caprine OB have been reported (Qu et al. 2008), where low doses of NaF stimulated proliferation and higher doses inhibited proliferation after 48 h of culture, and such divergent effects of NaF on caprine OB proliferation were observed through 96 h of culture. However, in the present studies, all doses of NaF tested inhibited OB proliferation following 96 h of culture. Treatment with NaF increased chicken embryonic OB proliferation in vitro and increased bone formation in embryonic calvaria cultures at concentrations that stimulated bone formation in vivo (Farley et al. 1983) and no inhibitory effects of NaF treatment on chick embryonic OB proliferation were observed. The duration of exposure of chicken embryonic OB to NaF was much shorter than that in described studies, suggesting that negative effects of NaF on OB proliferation are not acute, but rather require more prolonged NaF exposure. However, culture of human OB for up to 4 months in the presence of NaF did not influence OB proliferation (Chavassieux et al. 1993). Hence, reported effects of NaF treatment on OB proliferation are clearly variable.

The numbers of OB in bone (survival) are influenced by the equilibrium between rates of cell proliferation and cell death. Thus, effects of various NaF treatments (for 24 and 72 h) on OB apoptosis were also determined in the present studies. Results demonstrate that cultured neonatal rat OB are highly sensitive and respond to concentrations of NaF as low as 0.5 mg/ml (within 24 h) with a significant increase in apoptosis. Up to 10% of cells treated with the maximal dose of NaF (20 mg/l) were found to be in the early stages of apoptosis following 72 h of exposure in vitro. Acute effects of F exposure on bone-derived cell apoptosis have been reported previously. Apoptosis was detected within 8 h of F treatment of UMR 106 osteosarcoma cells (Hirano and Ando 1997) and NaF-induced apoptosis of caprine OB was recently reported (Qu et al. 2008), but effects of NaF on OB apoptosis were only examined following 48 h of treatment in the latter study. Even more pronounced effects of NaF on OB cell apoptosis were found following 72 h of exposure in the present studies. Furthermore, long-term exposure of female rats to NaF through the drinking water prior to mating resulted in a decrease in OB numbers in calvaria of offspring and increased incidence of apoptosis (Zhong et al. 2005). Collectively, results of above described studies support a potential role for increased OB apoptosis as a potential causative factor in the abnormal bone metabolism characteristic of F-induced skeletal disease.

One of the molecular hallmarks of apoptosis is the activation of caspases (Thornberry and Lazebnik 1998). The caspases are a subfamily of cysteine proteases that play an active regulatory role in the apoptotic cascade. Based on their order of activation, the caspases are classified into two families: the initiator and the effector caspases (Shi 2002). Caspase-9 is the key initiator caspase for the intrinsic pathway to cell death. Upon cleavage and activation from its proform, caspase-9 cleaves and activates caspase-3, the key effector caspase. Activation of caspase-3 leads to cytoskeletal breakdown and nuclear demise (Shi 2002). Hence, to gain initial insight into potential mechanisms involved in NaF-induced OB apoptosis, effects of NaF treatment for 24 and 72 h on OB cell mRNA for caspase-3 and caspase-9 were determined. Results demonstrate a stimulatory, dose dependent effect of NaF treatment on caspase-3 and caspase-9 mRNA abundance following 72 h of treatment. To our knowledge, effects of F treatment on caspase-3 and caspase-9 mRNA abundance have not been reported previously.

Elucidation of the mechanisms involved in F-induced OB apoptosis will require further investigation. Based on above results, a potential role for caspase-9 and the intrinsic, mitochondrial pathway (Dragovich et al. 1998) in NaF-induced apoptosis seems plausible. Oxidative stress induced by F treatment in vitro (Xu et al. 2008) and in vivo (Shivarajashankara et al. 2001) may trigger cytochrome c release and activation of the intrinsic pathway of apoptosis. However, further experiments would be required to confirm a functional role for caspase-9 in NaF-induced OB apoptosis, including measurement of caspase-9 activity and mitochondrial cytochrome c release (Dragovich et al. 1998). In addition, NaF-induced apoptosis of human gingival fibroblasts is mediated by both the mitochondrial (intrinsic) and death receptor (extrinsic) apoptotic pathways (Lee et al. 2008). Hence the involvement of the extrinsic pathway in NaF-induced OB apoptosis also merits further investigation.

In summary, results of described in vitro studies demonstrate a pronounced negative effect of NaF treatment on indices of OB survival, including decreased proliferation, increased apoptosis and increased caspase-3 and caspase-9 mRNA. Results support a potential role for reduced OB cell survival in the abnormal bone metabolism associated with skeletal disease induced by chronic, excessive F exposure. Further study will be required to elucidate the intracellular and extracellular mechanisms associated with NaF-induced OB apoptosis and potential therapeutic targets.